Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Lung Cancer treatment details. Biologic therapy. Tohoku University, Sendai, Japan

Survival: ?
Toxicity Grade: 3
Treatments: Biologic therapy
Country: Japan
City/State/Province: Sendai
Hospital: Tohoku University
Journal: Link
Date: 7/2006

Patients: This Phase II trial involved a total of 75 patients with advanced non-small-cell lung cancer. There were 30 men and 45 women. Subtypes included adenocarcinoma (64 patients) and non-adenocarcinoma (11 patients). None of the patients had previous chemotherapy.

Treatment: The treatment consisted of biological therapy Iressa (Gefitinib) an oral tyrosine kinase inhibitor of the epidermal growth factor receptor.

Toxicity: Grade 3 toxicities included elevation of a hepatic enzyme.

Results: The median overall survival was not reported.

Correspondance: Akira Inoue, MD

E-mail to a Friend Email Physician More Information